Starling Oncology (STLNW) Short term Debt (2020 - 2021)
Starling Oncology's (STLNW) quarterly Short term Debt came in at $183000.0 in Q4 2021, down 96.59% on a YoY basis from $5.4 million in Q4 2020, and down 96.59% quarter-over-quarter from $5.4 million in Q4 2020.
Powered by 
Analysis
Starling Oncology (STLNW) Short term Debt (2020 - 2021) Analysis & Trends
Starling Oncology (STLNW) has reported Short term Debt for 2 consecutive years, with $183000.0 the latest figure, recorded in Q4 2021.
- For the quarter ending Q4 2021, Short term Debt fell 96.59% year-over-year to $183000.0; the trailing twelve-month figure through Dec 2021 stood at $183000.0 (down 96.59% YoY), and the FY2021 full-year result was $183000.0, down 96.59% from the prior year.
- Short term Debt eased to $183000.0 in Q4 2021 per STLNW's latest filing, from $5.4 million in the prior quarter.
- Across five years, Short term Debt topped out at $5.4 million in Q4 2020 and bottomed at $183000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn |